Pegylated Interferon α-2b, Ribavirin and Amantadine for Chronic Hepatitis C

By Younossi Zobair   McCullough Arthur   Barnes David   Post Anthony   Ong Janus   O’shea Robert   Martin Lisa   Bringman Diane   Farmer Denise   Levinthal Gavin   Mullen Kevin   Carey William   Tavill Anthony   Ferguson Roy   Gramlich Terry  

Digestive Diseases and Sciences, Vol. 50, Iss. 5, 2005-05 ,pp. : 970-975

Springer Publishing Company

Access to resources Recommend Favorite

Mutations in the interferon sensitivity determining region and virological response to combination therapy with pegylated-interferon alpha 2b plus ribavirin in patients with chronic hepatitis C-1b infection

By Nakagawa Mina   Sakamoto Naoya   Ueyama Mayumi   Mogushi Kaoru   Nagaie Satoshi   Itsui Yasuhiro   Azuma Seishin   Kakinuma Sei   Tanaka Hiroshi   Enomoto Nobuyuki   Watanabe Mamoru  

Journal of Gastroenterology, Vol. 45, Iss. 6, 2010-06 ,pp. : 656-665

Springer Publishing Company

Access to resources Recommend Favorite

Prediction of Response to Pegylated Interferon/Ribavirin Combination Therapy for Chronic Hepatitis C Genotypes 2a and 2b and High Viral Load

By  

Digestive Diseases, Vol. 31, Iss. 5-6, 2013-11 ,pp. : 426-433

Karger

Access to resources Recommend Favorite

Prediction of Sustained Virological Response to Combination Therapy with Pegylated Interferon Alfa and Ribavirin in Patients with Genotype 3 Chronic Hepatitis C

By Tohra S.  

Digestive Diseases and Sciences, Vol. 56, Iss. 8, 2011-08 ,pp. : 2449-2455

Springer Publishing Company

Access to resources Recommend Favorite

Pegylated interferon and ribavirin combination therapy for chronic hepatitis C virus infection in patients with Child-Pugh Class A liver cirrhosis

By Syed Eliya   Rahbin Nogol   Weiland Ola   Carlsson Tony   Oksanen Antti   Birk Markus   Davidsdottir Loa   Hagen Karin   Hultcrantz Rolf   Aleman Soo  

Scandinavian Journal of Gastroenterology, Vol. 43, Iss. 11, 2008-01 ,pp. : 1378-1386

Informa Healthcare

Access to resources Recommend Favorite